Available  ||| S:0 E:10 ||| JJ
resources  ||| S:10 E:20 ||| NNS
for  ||| S:20 E:24 ||| IN
the  ||| S:24 E:28 ||| DT
treatment  ||| S:28 E:38 ||| NN
of  ||| S:38 E:41 ||| IN
breast  ||| S:41 E:48 ||| JJ
cancer  ||| S:48 E:55 ||| NN
in  ||| S:55 E:58 ||| IN
Mexico  ||| S:58 E:65 ||| NNP
Describe  ||| S:65 E:74 ||| NNP
the  ||| S:74 E:78 ||| DT
resources  ||| S:78 E:88 ||| NNS
for  ||| S:88 E:92 ||| IN
the  ||| S:92 E:96 ||| DT
treatment  ||| S:96 E:106 ||| NN
of  ||| S:106 E:109 ||| IN
breast  ||| S:109 E:116 ||| JJ
cancer  ||| S:116 E:123 ||| NN
in  ||| S:123 E:126 ||| IN
Mexico ||| S:126 E:132 ||| NNP
.  ||| S:132 E:134 ||| .
Information  ||| S:134 E:146 ||| NNP
was  ||| S:146 E:150 ||| VBD
obtained  ||| S:150 E:159 ||| VBN
from  ||| S:159 E:164 ||| IN
23  ||| S:164 E:167 ||| CD
Centros  ||| S:167 E:175 ||| NNP
Estatales  ||| S:175 E:185 ||| NNP
de  ||| S:185 E:188 ||| NNP
Cáncer  ||| S:188 E:195 ||| NNP
( ||| S:195 E:196 ||| -LRB-
State  ||| S:196 E:202 ||| NNP
Cancer  ||| S:202 E:209 ||| NNP
Centers ||| S:209 E:216 ||| NNPS
,  ||| S:216 E:218 ||| ,
CEC ||| S:218 E:221 ||| NNP
) ||| S:221 E:222 ||| -RRB-
,  ||| S:222 E:224 ||| ,
two  ||| S:224 E:228 ||| CD
federal  ||| S:228 E:236 ||| JJ
hospitals  ||| S:236 E:246 ||| NNS
and  ||| S:246 E:250 ||| CC
Cancerología ||| S:250 E:262 ||| NNP
.  ||| S:262 E:264 ||| .
This  ||| S:264 E:269 ||| DT
study  ||| S:269 E:275 ||| NN
was  ||| S:275 E:279 ||| VBD
performed  ||| S:279 E:289 ||| VBN
in  ||| S:289 E:292 ||| IN
Mexico  ||| S:292 E:299 ||| NNP
City  ||| S:299 E:304 ||| NNP
in  ||| S:304 E:307 ||| IN
August ||| S:307 E:313 ||| NNP
/ ||| S:313 E:314 ||| NNP
September  ||| S:314 E:324 ||| NNP
of  ||| S:324 E:327 ||| IN
2008 ||| S:327 E:331 ||| CD
.  ||| S:331 E:333 ||| .
These  ||| S:333 E:339 ||| DT
23  ||| S:339 E:342 ||| CD
centers  ||| S:342 E:350 ||| NNS
provide  ||| S:350 E:358 ||| VBP
medical  ||| S:358 E:366 ||| JJ
care  ||| S:366 E:371 ||| NN
for  ||| S:371 E:375 ||| IN
breast  ||| S:375 E:382 ||| JJ
cancer  ||| S:382 E:389 ||| NN
including  ||| S:389 E:399 ||| VBG
surgery ||| S:399 E:406 ||| NN
,  ||| S:406 E:408 ||| ,
chemotherapy  ||| S:408 E:421 ||| NN
and  ||| S:421 E:425 ||| CC
radiotherapy ||| S:425 E:437 ||| NNS
;  ||| S:437 E:439 ||| :
all  ||| S:439 E:443 ||| DT
of  ||| S:443 E:446 ||| IN
them  ||| S:446 E:451 ||| PRP
validated  ||| S:451 E:461 ||| VBD
by  ||| S:461 E:464 ||| IN
the  ||| S:464 E:468 ||| DT
Seguro  ||| S:468 E:475 ||| NNP
Popular ||| S:475 E:482 ||| NNP
.  ||| S:482 E:484 ||| .
The  ||| S:484 E:488 ||| DT
costs  ||| S:488 E:494 ||| NNS
were  ||| S:494 E:499 ||| VBD
defined  ||| S:499 E:507 ||| VBN
according  ||| S:507 E:517 ||| VBG
to  ||| S:517 E:520 ||| TO
clinical  ||| S:520 E:529 ||| JJ
stage  ||| S:529 E:535 ||| NN
and  ||| S:535 E:539 ||| CC
ranged  ||| S:539 E:546 ||| VBD
from  ||| S:546 E:551 ||| IN
$ ||| S:551 E:552 ||| $
27,500.00  ||| S:552 E:562 ||| CD
pesos  ||| S:562 E:568 ||| NNS
for  ||| S:568 E:572 ||| IN
clinical  ||| S:572 E:581 ||| JJ
stage  ||| S:581 E:587 ||| NN
0  ||| S:587 E:589 ||| CD
to  ||| S:589 E:592 ||| TO
$ ||| S:592 E:593 ||| $
480,00.00  ||| S:593 E:603 ||| CD
in  ||| S:603 E:606 ||| IN
the  ||| S:606 E:610 ||| DT
advanced  ||| S:610 E:619 ||| JJ
stage ||| S:619 E:624 ||| NN
.  ||| S:624 E:626 ||| .
A  ||| S:626 E:628 ||| DT
total  ||| S:628 E:634 ||| NN
of  ||| S:634 E:637 ||| IN
2  ||| S:637 E:639 ||| CD
689  ||| S:639 E:643 ||| CD
women  ||| S:643 E:649 ||| NNS
with  ||| S:649 E:654 ||| IN
breast  ||| S:654 E:661 ||| JJ
cancer  ||| S:661 E:668 ||| NN
have  ||| S:668 E:673 ||| VBP
been  ||| S:673 E:678 ||| VBN
treated ||| S:678 E:685 ||| VBN
;  ||| S:685 E:687 ||| :
only  ||| S:687 E:692 ||| RB
1 ||| S:692 E:693 ||| CD
%  ||| S:693 E:695 ||| NN
was  ||| S:695 E:699 ||| VBD
reported  ||| S:699 E:708 ||| VBN
with  ||| S:708 E:713 ||| IN
in  ||| S:713 E:716 ||| IN
situ  ||| S:716 E:721 ||| JJ
carcinoma ||| S:721 E:730 ||| NN
.  ||| S:730 E:732 ||| .
An  ||| S:732 E:735 ||| DT
adequate  ||| S:735 E:744 ||| JJ
medical  ||| S:744 E:752 ||| JJ
infrastructure  ||| S:752 E:767 ||| NN
is  ||| S:767 E:770 ||| VBZ
in  ||| S:770 E:773 ||| IN
place  ||| S:773 E:779 ||| NN
to  ||| S:779 E:782 ||| TO
treat  ||| S:782 E:788 ||| VB
breast  ||| S:788 E:795 ||| JJ
cancer  ||| S:795 E:802 ||| NN
in  ||| S:802 E:805 ||| IN
Mexico ||| S:805 E:811 ||| NNP
.  ||| S:811 E:813 ||| .
The  ||| S:813 E:817 ||| DT
costs  ||| S:817 E:823 ||| NNS
are  ||| S:823 E:827 ||| VBP
high  ||| S:827 E:832 ||| JJ
due  ||| S:832 E:836 ||| JJ
to  ||| S:836 E:839 ||| TO
late  ||| S:839 E:844 ||| JJ
diagnosis  ||| S:844 E:854 ||| NN
of  ||| S:854 E:857 ||| IN
the  ||| S:857 E:861 ||| DT
disease ||| S:861 E:868 ||| NN
.  ||| S:868 E:870 ||| .
Early  ||| S:870 E:876 ||| JJ
detection  ||| S:876 E:886 ||| NN
of  ||| S:886 E:889 ||| IN
breast  ||| S:889 E:896 ||| JJ
cancer  ||| S:896 E:903 ||| NN
is  ||| S:903 E:906 ||| VBZ
a  ||| S:906 E:908 ||| DT
high  ||| S:908 E:913 ||| JJ
priority  ||| S:913 E:922 ||| NN
for  ||| S:922 E:926 ||| IN
optimal  ||| S:926 E:934 ||| JJ
control  ||| S:934 E:942 ||| NN
of  ||| S:942 E:945 ||| IN
this  ||| S:945 E:950 ||| DT
disease  ||| S:950 E:958 ||| NN
in  ||| S:958 E:961 ||| IN
Mexico ||| S:961 E:967 ||| NNP
.  ||| S:967 E:969 ||| .
